Phase 2a trial of AT-004
Latest Information Update: 29 Jan 2025
Price :
$35 *
At a glance
- Drugs AT-004 (Primary)
- Indications Acne vulgaris
- Focus Therapeutic Use
- 29 Jan 2025 New trial record
- 22 Jan 2025 According to Arctic Therapeutics, company is planning to launch a phase IIa clinical trial for AT-004 in Europe post-financing.